Longitudinal Study of the Ocular Complications of AIDS. 1. Ocular Diagnoses at Enrollment

Research output: Contribution to journalArticle

Abstract

Objective: To report the prevalence of ocular complications of AIDS in the era of highly active antiretroviral therapy (HAART). Design: Cohort study. Participants: Patients with AIDS, 13 years or older. Methods: History, eye examination, and laboratory testing at enrollment. Main Outcome Measure: Frequency of ocular complications at enrollment. Results: As of March 31, 2003, 1632 participants with AIDS were enrolled. The cohort had a history of severe immune deficiency, as evidenced by a median nadir CD4+ T-cell count of 30 cells per microliter. At enrollment, the median CD4+ T-cell count was 164 cells per microliter. CD4+ T-cell counts were

Original languageEnglish (US)
JournalOphthalmology
Volume114
Issue number4
DOIs
StatePublished - Apr 2007

Fingerprint

CD4 Lymphocyte Count
Longitudinal Studies
Acquired Immunodeficiency Syndrome
T-Lymphocytes
Highly Active Antiretroviral Therapy
Cohort Studies
History
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Longitudinal Study of the Ocular Complications of AIDS. 1. Ocular Diagnoses at Enrollment. / Jabs, Douglas; Van Natta, Mark L; Holbrook, Janet Teresa; Kempen, John H.; Meinert, Curtis L; Davis, Matthew D.

In: Ophthalmology, Vol. 114, No. 4, 04.2007.

Research output: Contribution to journalArticle

@article{b6a3b6c633254b24b5b353a16f73fa0a,
title = "Longitudinal Study of the Ocular Complications of AIDS. 1. Ocular Diagnoses at Enrollment",
abstract = "Objective: To report the prevalence of ocular complications of AIDS in the era of highly active antiretroviral therapy (HAART). Design: Cohort study. Participants: Patients with AIDS, 13 years or older. Methods: History, eye examination, and laboratory testing at enrollment. Main Outcome Measure: Frequency of ocular complications at enrollment. Results: As of March 31, 2003, 1632 participants with AIDS were enrolled. The cohort had a history of severe immune deficiency, as evidenced by a median nadir CD4+ T-cell count of 30 cells per microliter. At enrollment, the median CD4+ T-cell count was 164 cells per microliter. CD4+ T-cell counts were",
author = "Douglas Jabs and {Van Natta}, {Mark L} and Holbrook, {Janet Teresa} and Kempen, {John H.} and Meinert, {Curtis L} and Davis, {Matthew D.}",
year = "2007",
month = "4",
doi = "10.1016/j.ophtha.2006.11.008",
language = "English (US)",
volume = "114",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Longitudinal Study of the Ocular Complications of AIDS. 1. Ocular Diagnoses at Enrollment

AU - Jabs, Douglas

AU - Van Natta, Mark L

AU - Holbrook, Janet Teresa

AU - Kempen, John H.

AU - Meinert, Curtis L

AU - Davis, Matthew D.

PY - 2007/4

Y1 - 2007/4

N2 - Objective: To report the prevalence of ocular complications of AIDS in the era of highly active antiretroviral therapy (HAART). Design: Cohort study. Participants: Patients with AIDS, 13 years or older. Methods: History, eye examination, and laboratory testing at enrollment. Main Outcome Measure: Frequency of ocular complications at enrollment. Results: As of March 31, 2003, 1632 participants with AIDS were enrolled. The cohort had a history of severe immune deficiency, as evidenced by a median nadir CD4+ T-cell count of 30 cells per microliter. At enrollment, the median CD4+ T-cell count was 164 cells per microliter. CD4+ T-cell counts were

AB - Objective: To report the prevalence of ocular complications of AIDS in the era of highly active antiretroviral therapy (HAART). Design: Cohort study. Participants: Patients with AIDS, 13 years or older. Methods: History, eye examination, and laboratory testing at enrollment. Main Outcome Measure: Frequency of ocular complications at enrollment. Results: As of March 31, 2003, 1632 participants with AIDS were enrolled. The cohort had a history of severe immune deficiency, as evidenced by a median nadir CD4+ T-cell count of 30 cells per microliter. At enrollment, the median CD4+ T-cell count was 164 cells per microliter. CD4+ T-cell counts were

UR - http://www.scopus.com/inward/record.url?scp=33947605551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947605551&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2006.11.008

DO - 10.1016/j.ophtha.2006.11.008

M3 - Article

C2 - 17258320

AN - SCOPUS:33947605551

VL - 114

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 4

ER -